EHDEN Webinar – What could the pharma industry look like by 2030 – digital discovery, R&D and post-authorisation?
Science is leading us down the path of increasingly targeted medicines with accompanying advances in
Science is leading us down the path of increasingly targeted medicines with accompanying advances in
With the growing use of regulatory tools such as conditional approvals and breakthrough designations, the
The Covid-19 pandemic underscores the need for high-quality health data that is readily deployed. Europe’s